Search results
Showing 16 to 20 of 20 results for aflibercept
associated with inconvenience, risk of adverse events and – especially when aflibercept or ranibizumab is used – substantial costs....
raltitrexed 8 January 2002 TA307 Colorectal cancer (metastatic) – aflibercept 23 January 2014 TA118 Colorectal cancer (metastatic) -...
Ranibizumab for treating choroidal neovascularisation associated with pathological myopia (TA298)
Evidence-based recommendations on ranibizumab (Lucentis) for treating choroidal neovascularisation associated with pathological myopia in adults.
Visual impairment due to myopic choroidal neovascularisation: aflibercept (ESNM76)
This evidence summary has been replaced by NICE technology appraisal guidance 486.
NICE recommends faricimab as treatment option for adults with wet age-related macular degeneration or diabetic macular oedema